Vireo Growth Inc Stock Price, News & Analysis

Vireo Growth Inc. (OTCQX: VREOF) reported strong Q2 2025 financial results, with GAAP revenue reaching $48.1 million, a 91.4% increase year-over-year. The company completed three significant merger acquisitions in Utah, Missouri, and Nevada, expanding operations to six states. Key financial metrics include Adjusted EBITDA of $13.3 million and pro forma revenue of $90.7 million.

Notably, Vireo secured a $153 million refinancing, comprising a $120 million term loan at 8.3% interest and a $33 million second lien term loan with a $50 million accordion feature. This refinancing is expected to reduce annual interest expenses by over $10 million and has strengthened the company's balance sheet with over $100 million in cash.

Vireo Growth (OTCQX: VREOF) has scheduled its second quarter 2025 financial results release for August 13, 2025, before market opening. The company will host a conference call with investors on the same day at 8:30 a.m. ET to discuss the quarterly performance.

Investors can join the call by dialing 1-800-715-9871 (US/Canada toll-free) or 1-646-307-1963 (International) with conference ID 3718174. A live webcast will be available through the company's Investor Relations website.

Vireo Growth (OTCQX:VREOF) has announced the retirement of its US$10 million convertible note that was due November 1, 2024. The company has simultaneously issued a new US$10 million convertible note on July 7, 2025, as part of a larger refinancing initiative.

The transaction is classified as a "related party transaction" under MI 61-101, as the lender is considered a related party to Vireo. However, the transaction is exempt from formal valuation and minority shareholder approval requirements since the value does not exceed 25% of Vireo's market capitalization.

Vireo Growth (OTCQX:VREOF) has successfully completed a major debt refinancing and expansion of its credit facilities. The company secured a $120 million self-syndicated first lien term loan at 8.3% interest rate and a $33 million second lien term loan with a $50 million accordion feature.

The total $153 million financing package is expected to generate over $10 million in annual interest savings and provides the company with more than $100 million in cash. The refinancing consolidates debt assumed from recent mergers and optimizes the company's capital structure. Both facilities have three-year terms and can be prepaid without penalties.

Vireo Growth Inc. (OTCQX: VREOF) has announced a strategic licensing partnership with Curio Wellness to manufacture and distribute Curio's Best Self Collection products in New York's cannabis market. The agreement enables Vireo to produce and distribute Curio's complete product portfolio, including topicals, tablets, chews, and vapes, using Vireo's existing New York infrastructure.

This capital-efficient growth strategy allows Curio to enter the New York market without significant investment, while Vireo expands its portfolio with Curio's GMP-certified, nationally recognized products. The partnership leverages Vireo's established presence in New York and Curio's reputation for quality and consistency in health and wellness cannabis products.

The companies expect to launch Curio-branded products in New York dispensaries in Q4 2025.

Vireo Growth Inc. (VREOF) has provided significant corporate updates following the completion of multiple merger transactions that have established it as a major U.S. multi-state cannabis operator with operations in six states. The company projects Q2 2025 pro forma revenue of $88-91 million and adjusted EBITDA of $23-24 million, assuming merger closings as of April 1, 2025. Vireo is actively pursuing debt refinancing with multiple non-binding term sheets signed for its senior secured debt, expecting more favorable terms due to improved profitability. Post-refinancing, the company anticipates a cash position exceeding $100 million. Following the mergers, Vireo reports 949,254,483 basic shares outstanding on an as-converted basis and 1,087,283,616 shares on a fully-diluted basis.

Vireo Growth Inc. (VREOF) has completed its acquisition of Deep Roots Holdings, a Nevada-based cannabis operator, for $132.7 million in an all-stock transaction. The deal involves issuing 255.2 million Subordinate Voting Shares at $0.52 per share. Deep Roots, established in 2023, operates a 54,000 square foot cultivation and manufacturing facility and ten retail dispensaries in Nevada, with strategic locations near the Utah border. The company also holds investments in California, Ohio, and Massachusetts operations. The purchase price represents 4.175x Deep Roots' 2024 Closing EBITDA of $30 million, with clawback provisions if 2026 EBITDA falls below the Closing EBITDA. Selling shareholders agreed to a 33-month phased lock-up period for their shares.

Vireo Growth has completed its acquisition of Proper Brands in Missouri through its subsidiaries NGH Investments and Proper Holdings Management. The deal, valued at $102.0 million, was paid entirely in Vireo stock with 196.2 million Subordinate Voting Shares at $0.52 per share. Proper Brands, established in 2022, operates 11 retail dispensaries primarily in St. Louis, with one location in Kansas City and an additional undeveloped license. The company features a 100,000+ square foot cultivation and manufacturing facility and is implementing the Arches technology platform for home delivery. The purchase price represents 4.175x Proper's 2024 Closing EBITDA of $31 million. The deal includes clawback provisions tied to 2026 EBITDA performance and share lock-up provisions spanning 33 months.

Vireo Growth Inc. (VREOF) has successfully closed two strategic acquisitions: WholesomeCo Cannabis, a dominant player in Utah's medical market, and the Arches proprietary technology platform for a total of $69.8 million. The deal was executed through 134.2 million Subordinate Voting Shares at $0.52 per share.

The Wholesome acquisition, valued at 4.175x its 2024 Reference EBITDA of $16 million, includes clawback provisions tied to performance milestones through December 2026. Shareholders agreed to a 33-month lock-up period. The company also expects to close pending mergers in Missouri and Nevada in Q2 2025.